Literature DB >> 1805399

Investigation of the portal perfusion index after low diameter mesocaval interposition and distal splenorenal shunt--a prospective study.

K J Paquet1, M A Mercado, H Klingele, R Klingele.   

Abstract

In 50 consecutive patients portal blood flow was determined using computed liver perfusion scintigraphy preoperatively and at 6, 12, 24, 36, 48, 60, 72, and 84 months postoperatively between 1 January 1983 and 1 January 1990. All 25 subjects had undergone placement of a distal splenorenal shunt (DSRS) and 25, insertion of low-diameter PTFE mesocaval interposition shunt (LDMIS) between 15 January 1983 and 1 January 1988. Indications for shunt operation included recurrent variceal hemorrhage in spite of long-term endoscopic sclerotherapy, a Child-Pugh classification of A or B, a sonographically determined liver volume of between 1000 and 2500 ml, exclusion of the activity and progression of liver disease by biopsy and stenosis of the hepatic artery or coeliac trunk. DSRS was performed when the portal perfusion index (PPI) was greater than 30% (normal values 56 +/- 5%) and LDMIS was carried out when the PPI was 10% to 30%. In all cases the underlying disease was liver cirrhosis of alcoholic (n = 34, 68%) or hepatic (n = 12, 24%) etiology. Five patients who underwent LDMIS had originally scheduled for DSRS at a PPI of greater than 30%; because the DSRS would have been technically difficult due to severe chronic pancreatitis, a LDMIS was performed. One in-hospital death due to liver failure had occurred in each group by 1 January 1990. One patient in the DSRS group and two in the LDMIS group died later, and in each group one patient was lost to follow-up.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1991        PMID: 1805399     DOI: 10.1007/BF02653265

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  23 in total

Review 1.  Etiology and pathophysiology of portal hypertension.

Authors:  J Reichen
Journal:  Z Gastroenterol       Date:  1988-09       Impact factor: 2.000

2.  Improved results with selective distal splenorenal shunt in a highly selected patient population. A prospective study.

Authors:  K J Paquet; M A Mercado; P Koussouris; J F Kalk; F Siemens; F Cuan-Orozco
Journal:  Ann Surg       Date:  1989-08       Impact factor: 12.969

3.  Prospective evaluation and long-term results of mesocaval interposition shunts.

Authors:  K J Paquet; J F Kalk; P Koussouris
Journal:  Acta Chir Scand       Date:  1987 Jul-Aug

4.  [Liver perfusion scintigraphy: method, normal values and results of observations on the course of patients with esophageal varices].

Authors:  E Moser; B Oxenius; T Sauerbruch
Journal:  Nuklearmedizin       Date:  1985-08       Impact factor: 1.379

5.  Hemodynamic differences between alcoholic and nonalcoholic cirrhotics following distal splenorenal shunt--effect on survival?

Authors:  J M Henderson; W J Millikan; L Wright-Bacon; M H Kutner; W D Warren
Journal:  Ann Surg       Date:  1983-09       Impact factor: 12.969

6.  Comparison of distal and proximal splenorenal shunts: a randomized prospective trial.

Authors:  J E Fischer; R H Bower; S Atamian; R Welling
Journal:  Ann Surg       Date:  1981-10       Impact factor: 12.969

7.  Predictability and maintenance of portal flow patterns after small-diameter portacaval H-grafts in man.

Authors:  E B Rypins; G R Mason; R M Conroy; I J Sarfeh
Journal:  Ann Surg       Date:  1984-12       Impact factor: 12.969

8.  Dacron interposition shunts for portal hypertension. An analysis of morbidity correlates.

Authors:  R B Smith; W D Warren; A A Salam; W J Millikan; J D Ansley; J T Galambos; M Kutner; R P Bain
Journal:  Ann Surg       Date:  1980-07       Impact factor: 12.969

9.  A systematic appraisal of portacaval H-graft diameters. Clinical and hemodynamic perspectives.

Authors:  I J Sarfeh; E B Rypins; G R Mason
Journal:  Ann Surg       Date:  1986-10       Impact factor: 12.969

10.  Distal splenorenal shunt versus endoscopic sclerotherapy for long-term management of variceal bleeding. Preliminary report of a prospective, randomized trial.

Authors:  W D Warren; J M Henderson; W J Millikan; J T Galambos; W S Brooks; S P Riepe; A A Salam; M H Kutner
Journal:  Ann Surg       Date:  1986-05       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.